Halper Sadeh LLC Urges Shareholders of FFWM, AKRO, CCRD to Assert Their Rights Promptly
Halper Sadeh LLC, a prominent law firm dedicated to protecting investor rights, has recently initiated investigations into several companies that may have breached federal securities laws and fiduciary duties owed to shareholders. These investigations focus on First Foundation Inc. (NYSE: FFWM), Akero Therapeutics, Inc. (NASDAQ: AKRO), and CoreCard Corporation (NYSE: CCRD). The firm emphasizes the importance of shareholders contacting them as time is limited to exercise their legal rights.
The investigation into First Foundation centers on its proposed sale to FirstSun Capital Bancorp. Each shareholder of First Foundation is set to receive approximately 0.16083 shares of FirstSun common stock per share they own of First Foundation common stock. Halper Sadeh LLC is probing whether this exchange is equitable and whether shareholders are being provided with all necessary information to make informed decisions about the transaction.
In the case of Akero, the law firm is looking into its potential sale to Novo Nordisk A/S, where Akero shareholders would be compensated with $54.00 per share in cash. Additionally, they would receive a non-transferable Contingent Value Right (CVR) that grants a cash payment of up to $6.00 per share, contingent upon the approval of a drug called efruxifermin by June 30, 2031. This two-party agreement raises concerns regarding whether shareholders are being afforded adequate value for their shares and whether all relevant disclosures are being made.
As for CoreCard, Halper Sadeh is investigating the circumstances surrounding its sale to Euronet, which proposes an exchange ratio between 0.2783 and 0.3142 shares of Euronet common stock for each CoreCard share. Similar to FFWM and AKRO, the concern lies in whether shareholders will receive a fair deal as well as sufficient information regarding their rights and options during this transition.
Halper Sadeh LLC's investigations aim to safeguard shareholder interests and potentially seek higher consideration during these acquisitions while ensuring full compliance with disclosure laws. Shareholders are encouraged to take action swiftly; thus, they are invited to reach out to the firm for a complimentary discussion about their legal standing.
Attorney Daniel Sadeh and Zachary Halper are available for inquiries, providing assurance that their law firm operates on a contingency fee basis. This means clients won’t incur out-of-pocket expenses for legal fees unless a recovery is achieved. Halper Sadeh LLC is recognized globally for representing investors who have faced corporate fraud, having successfully advocated for essential corporate reforms and recovery of funds for defrauded investors.
Shareholders of FFWM, AKRO, and CCRD should not hesitate to exercise their rights and explore their options. The time to act may be limited, making immediate action crucial for safeguarding their investments. For more information or to initiate an inquiry, shareholders are encouraged to visit the Halper Sadeh LLC website or contact the firm directly.
Contact details for Halper Sadeh LLC:
Phone: (212) 763-0060
Email: [email protected]
Email: [email protected]
Website: www.halpersadeh.com
Halper Sadeh LLC remains committed to fighting for the rights and interests of investors everywhere.
First Foundation Inc. (NYSE: FFWM)
The investigation into First Foundation centers on its proposed sale to FirstSun Capital Bancorp. Each shareholder of First Foundation is set to receive approximately 0.16083 shares of FirstSun common stock per share they own of First Foundation common stock. Halper Sadeh LLC is probing whether this exchange is equitable and whether shareholders are being provided with all necessary information to make informed decisions about the transaction.
Akero Therapeutics, Inc. (NASDAQ: AKRO)
In the case of Akero, the law firm is looking into its potential sale to Novo Nordisk A/S, where Akero shareholders would be compensated with $54.00 per share in cash. Additionally, they would receive a non-transferable Contingent Value Right (CVR) that grants a cash payment of up to $6.00 per share, contingent upon the approval of a drug called efruxifermin by June 30, 2031. This two-party agreement raises concerns regarding whether shareholders are being afforded adequate value for their shares and whether all relevant disclosures are being made.
CoreCard Corporation (NYSE: CCRD)
As for CoreCard, Halper Sadeh is investigating the circumstances surrounding its sale to Euronet, which proposes an exchange ratio between 0.2783 and 0.3142 shares of Euronet common stock for each CoreCard share. Similar to FFWM and AKRO, the concern lies in whether shareholders will receive a fair deal as well as sufficient information regarding their rights and options during this transition.
Halper Sadeh LLC's investigations aim to safeguard shareholder interests and potentially seek higher consideration during these acquisitions while ensuring full compliance with disclosure laws. Shareholders are encouraged to take action swiftly; thus, they are invited to reach out to the firm for a complimentary discussion about their legal standing.
Attorney Daniel Sadeh and Zachary Halper are available for inquiries, providing assurance that their law firm operates on a contingency fee basis. This means clients won’t incur out-of-pocket expenses for legal fees unless a recovery is achieved. Halper Sadeh LLC is recognized globally for representing investors who have faced corporate fraud, having successfully advocated for essential corporate reforms and recovery of funds for defrauded investors.
Conclusion
Shareholders of FFWM, AKRO, and CCRD should not hesitate to exercise their rights and explore their options. The time to act may be limited, making immediate action crucial for safeguarding their investments. For more information or to initiate an inquiry, shareholders are encouraged to visit the Halper Sadeh LLC website or contact the firm directly.
Contact details for Halper Sadeh LLC:
Phone: (212) 763-0060
Email: [email protected]
Email: [email protected]
Website: www.halpersadeh.com
Halper Sadeh LLC remains committed to fighting for the rights and interests of investors everywhere.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.